Abnormal intracellular calcium handling in acute and chronic heart failure: role in systolic and diastolic

C L Perreault1, A J Meuse, L A Bentivegna

  • 1Charles A. Dana Research Institute, Beth Israel Hospital, Boston, Massachusetts 02215.

Insights

Heart failure stems from issues in excitation-contraction coupling, myocardial energetics, or extracellular factors. Abnormal intracellular calcium handling is a key driver of both acute and chronic heart dysfunction.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Biochemistry

Background:

  • Heart failure involves complex cardiac abnormalities.
  • Dysfunction can arise from excitation-contraction coupling, energetics, or extracellular changes.
  • Abnormal intracellular calcium handling is implicated in heart failure.

Purpose of the Study:

  • To investigate the underlying mechanisms of acute and chronic heart failure.
  • To differentiate the causes of dysfunction in various heart failure models.
  • To identify common pathways contributing to cardiac dysfunction.

Main Methods:

  • Studied animal and human models of acute cardiac failure (drug effects, hypoxia, ischemia).
  • Examined models of chronic cardiac dysfunction (pressure overload, cardiomyopathies, hypothyroidism).
  • Analyzed changes in excitation-contraction coupling, energetics, and extracellular factors.

Main Results:

  • Acute cardiac failure models predominantly showed excitation-contraction coupling defects.
  • Chronic models exhibited combined excitation-contraction coupling and extracellular factor abnormalities (myocyte loss, fibrosis).
  • Abnormal intracellular calcium handling was a major factor in both systolic and diastolic dysfunction across models.

Conclusions:

  • Excitation-contraction coupling and intracellular calcium handling are critical in acute heart failure.
  • Chronic heart failure involves a combination of cellular and extracellular matrix changes.
  • Targeting intracellular calcium handling may be a therapeutic strategy for heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
801